CJC-1295 with DAC dosing protocol explained: typical weekly dose, split schedules, stacking with ipamorelin, reconstitution, and safety notes.
The standard CJC-1295 with DAC dosing protocol is 1 to 2 mg per week, injected subcutaneously, either as one weekly dose or split into two doses of 0.5 to 1 mg. The Drug Affinity Complex (DAC) extends the peptide's half-life to roughly 6 to 8 days, so daily injections are not necessary. CJC-1295 with DAC is not FDA-approved for human use in the United States and is legally sold only as a research chemical.
What CJC-1295 With DAC Is and Why the DAC Matters
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). The "with DAC" version attaches a maleimide-based Drug Affinity Complex that binds covalently to albumin in the bloodstream.
That albumin binding is what separates CJC-1295 with DAC from the shorter-acting version, often called CJC-1295 no DAC or mod GRF (1-29). The DAC version stays active for days, while the no-DAC version clears in about 30 minutes.
- With DAC: half-life of about 6–8 days; weekly dosing.
- No DAC (mod GRF 1-29): half-life of about 30 minutes; dosed 2–3 times daily.
Standard CJC-1295 With DAC Dosing Protocol
Most published research and community protocols fall into a narrow range. The table below summarizes the most commonly cited schedules.
| Protocol | Weekly Dose | Injection Frequency | Notes |
|---|---|---|---|
| Conservative start | 1 mg | 0.5 mg twice weekly | Often used to gauge tolerance |
| Standard | 2 mg | 1 mg twice weekly or 2 mg once weekly | Most frequently referenced protocol |
| Weight-based | 60–90 mcg/kg | Once weekly | Mirrors some early clinical studies |
| Low-dose split | 1–2 mg | 100–200 mcg 2–3x weekly | Less common, anecdotal |
Doses are typically injected subcutaneously into the abdomen, thigh, or upper arm. Rotating sites reduces irritation.
Weekly vs. Split Dosing
A single 2 mg weekly injection is the simplest approach and matches the long half-life. Splitting into two 1 mg doses may produce steadier levels, though no head-to-head human data confirms an advantage.
Some users prefer splitting to reduce the chance of a large single-dose reaction. Others report no difference in results.
Timing and Injection Technique
Injecting before bed is common because natural growth hormone release peaks during sleep. Fasting for 1–2 hours before and after injection is also frequently recommended, since insulin can blunt GH release.
Use sterile technique, alcohol swabs, and a new needle each time. Never share injection equipment.
How Much CJC 1295 With DAC Should I Take?
If you are asking how much cjc 1295 with dac should i take, the honest answer is that there is no FDA-approved human dose. Research protocols typically use 1–2 mg per week, but individual response depends on age, body weight, baseline IGF-1, and overall health.
Common questions about cjc-1295 with dac dosage also involve timing, stacking, and whether to start low. A reasonable conservative approach is to begin at the low end of the range and avoid escalating quickly.
Because CJC-1295 with DAC raises growth hormone and IGF-1, it can affect blood sugar, fluid retention, and joint comfort. Anyone with diabetes, cancer history, or pituitary conditions should avoid it without medical supervision.
Stacking With Ipamorelin and Other Peptides
CJC-1295 with DAC is often combined with a ghrelin mimetic such as ipamorelin, GHRP-2, or GHRP-6. The combination targets two different receptors to produce a larger GH pulse.
Ipamorelin has a short half-life, so a typical cjc-1295 no dac ipamorelin protocol uses the no-DAC version dosed 2–3 times daily. When stacked with the DAC version, ipamorelin is still usually injected 2–3 times daily, while CJC-1295 with DAC is injected once or twice weekly.
Stacking increases the chance of side effects, including hunger, tingling, and water retention. More is not automatically better.
CJC-1295 With DAC 5mg Reconstitution and Storage
Most vials sold as cjc-1295 with dac 5mg contain 5 mg of lyophilized powder. Adding 2.5 mL of bacteriostatic water creates a concentration of 2 mg/mL.
- 1 mg dose = 0.5 mL (50 units on an insulin syringe)
- 2 mg dose = 1.0 mL (100 units)
- 0.5 mg dose = 0.25 mL (25 units)
Swirl gently; do not shake. Store reconstituted peptide in the refrigerator at 2–8°C and protect it from light. Discard if the solution becomes cloudy or contains particles.
Reported Side Effects and Safety Considerations
Reported effects include injection-site reactions, flushing, headache, fatigue, increased appetite, and mild fluid retention. More serious concerns include elevated IGF-1, insulin resistance, and potential effects on existing tumors.
CJC-1295 with DAC is not approved by the FDA for any human indication. Products labeled for research use are not tested for sterility, purity, or identity in the way pharmaceuticals are.
Talk with a licensed healthcare professional before using any peptide. Bloodwork and medical supervision matter more than any forum protocol.
What Users Discuss on Forums
Discussions tagged cjc 1295 with dac reddit often center on weekly dosing, stacking, and side effects. Anecdotes vary widely, and self-reported results are impossible to verify.
Forum reports are not clinical evidence. They can help you ask better questions, but they should never replace medical advice.
Frequently Asked Questions
How much CJC-1295 with DAC should I take per week?
Research protocols typically use 1 to 2 mg per week, injected subcutaneously as one weekly dose or split into two. There is no FDA-approved human dose, and individual response varies. A healthcare professional can help interpret bloodwork and assess risk.
Can I inject CJC-1295 with DAC every day?
No, daily injections are unnecessary. The DAC extends the half-life to roughly 6 to 8 days, so once-weekly or twice-weekly dosing is standard. The no-DAC version is the one that requires daily or multiple-daily injections.
Does CJC-1295 with DAC need to be stacked with ipamorelin?
It does not have to be, but the combination is popular because ipamorelin adds a separate GH-releasing pathway. Ipamorelin clears quickly and is usually injected 2 to 3 times daily even when CJC-1295 with DAC is dosed weekly. Stacking also raises the risk of side effects.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.